False-negative serological HLA-B27 typing results may be due to altered antigenic epitopes and can be detected by polymerase chain reaction

British Journal of Rheumatology

Volumn 36, Issue 2, 1997, Pages 185-189

  Kirveskari, J ^a   Kellner, H ^b   Wuorela, M ^c   Soini, H ^d   Frankenberger, B ^a   Leirisalo Repo, M ^c   Weiss, E H ^b   Granfors, K ^d  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

HLA typing; HLA B27; MLCT; PCR; Reactive arthritis; Yersinia

Indexed keywords

EPITOPE; HLA B27 ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; FLOW CYTOMETRY; HLA TYPING; HUMAN; LABORATORY DIAGNOSIS; LYMPHOCYTOTOXICITY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REACTIVE ARTHRITIS; REITER SYNDROME;

EID: 0030814248     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.2.185     Document Type: Article

References (29)

1. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet 1973;1:904-7.
2. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973;288:704-6.
3. Aho K, Ahvonen P, Lassus A, Sievers K, Tiilikainen A. HL-A 27 in reactive arthritis. A study of Yersinia arthritis and Reiter's disease. Arthritis Rheum 1974;17:521-6.
4. Leirisalo M, Skylv G, Kousa M et al. Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum 1982;25:249-9.
5. Inman RD, Scofield RH. Etiopathogenesis of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumatol 1994;6:360-70.
6. Feltkamp TEW, Khan MA, Lopez de Castro JA. The pathogenetic role of HLA-B27. Immunol Today 1996;17:5-7.
7. Otten HG, van Soest M, Bijlsma JWJ, de Gast GC. Clinical application of the polymerase chain reaction in the detection of HLA-B27 alleles. Clin Exp Rheumatol 1995;13:741-3.
8. Amor B, Kahan A, Georgiadis AE. Transient loss of HLA B27. Lancet 1978;1:284.
9. Neumüller J, Fischer M, Eberl R. Failure of the serological determination of HLA-B27 due to antigen masking in patients with ankylosing spondylitis. Rheumatol Int 1993;13:163-7.
10. Albrecht J, Muller HA. HLA-B27 typing by use of flow cytofluorometry. Clin Chem 1987;33:1619-23.
11. Otten GR, Bikoff E, Ribaudo RK, Kozlowski S, Margulies DH, Germain RN. Peptide and beta 2-microglobulin regulation of cell surface MHC class I conformation and expression. J Immunol 1992;148:3723-32.
12. Villadangos JA, Galocha B, Garcia F, Albar JP, Lopez de Castro JA. Modulation of peptide binding by HLA-B27 polymorphism in pockets A and B, and peptide specificity of B*2703. Eur J Immunol 1995;25:2370-7.
13. Scofield RH, Kurien B, Gross T, Warren WL, Harley JB. HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: implications for spondy-loarthropathies. Lancet 1995;345:1542-4.
14. Dominguez O, Coto E, Martinez Naves E, Choo SY, Lopez Larrea C. Molecular typing of HLA-B27 alleles. Immunoeenetics 1992;36:277-82.
15. Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Greenwood BM, McMichael AJ. HLA class I typing by PCR: HLA-B27 and an African B27 subtype. Lancet 1991;337:640-2.
16. Steffens Nakken HM, Zwart G, van den Bergh FA. Validation of allele-specific polymerase chain reaction for DNA typing of HLA-B27. Clin Chem 1995;41:687-92.
17. Olerup O. HLA-B27 typing by a group-specific PCR amplification. Tissue Antigens 1994;43:253-6.
18. Mercier B, Gaucher C, Feugeas O, Mazurier C. Direct PCR from whole blood, without DNA extraction. Nucleic Acids Res 1990;18:5908.
19. Soini H, Skurnik M, Liippo K, Tala E, Viljanen MK. Detection and identification of mycobacteria by amplification of a segment of the gene coding for the 32-kilodalton protein. J Clin Microbiol 1992;30:2025-8.
20. Grumet FC, Fendly BM, Engleman EG. Monoclonal anti-HLA-B27 antibody (B27M1): production and lack of detectable typing difference between patients with ankylosing spondylitis, Reiter's syndrome, and normal controls. Lancet 1981;2:170-6.
21. Taurog JD, el Zaatari FA. In vitro mutagenesis of HLA-B27. Substitution of an unpaired cysteine residue in the alpha 1 domain causes loss of antibody-defined epitopes. J Clin Invest 1988;82:987-92.
22. Pei R, Arjomand Shamsai M, Deng CT, Cesbron A, Bignon JD, Lee JH. A monospecific HLA-B27 fluorescein isothiocyanate-conjugated monoclonal antibody for rapid, simple and accurate HLA-B27 typing. Tissue Antigens 1993;41:200-3.
23. Parham P, Barnstable CJ, Bodmer WF. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens. J Immunol 1979;123:342-9.
24. Parham P, Antonelli P, Herzenberg LA, Kipps TJ, Fuller A, Ward FE. Further studies on the epitopes of HLA-B7 defined by murine monoclonal antibodies. Hum Immunol 1986;15:40-67.
25. Leirisalo Repo M, Suoranta H. Ten-year follow-up study of patients with Yersinia arthritis. Arthritis Rheum 1988;31:533-7.
26. Pfeifer JD, Wick MJ, Roberts RL, Findlay K, Normark SJ, Harding CV. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 1993;361:359-62.
27. Whelan MA, Archer JR. Chemical reactivity of an HLA-B27 thiol group. Eur J Immunol 1993;23:3278-85.
28. Keat AC, Thomas BJ, Taylor Robinson D, Pegrum GD, Maini RN, Scott JT. Evidence of Chlamydia trachomatis infection in sexually acquired reactive arthritis. Ann Rheum Dis 1980;39:431-7.
29. Partanen J, Koskimies S, Ilonen J, Knip M. HLA antigens and complotypes in insulin-dependent diabetes mellitus. Tissue Antigens 1986;27:291-7.